临床试验/IRCT20240204060900N1

IRCT20240204060900N1已完成3 期

Comparison of therapeutic effects of 3 methods of microneedling with TCA 50%, microneedling and peeling TCA 50% each alone in acral vitiligo

Esfahan University of Medical Sciences0 个研究点目标入组 21 人开始时间: 待定最近更新: 2024年3月6日

适应症

试验速览

阶段: 3 期
状态: 已完成
发起方: Esfahan University of Medical Sciences
入组人数: 21

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 11 years 至 60 years（—）
性别: All

入选标准

•Absence of active vitiligo for 2 years
•Not receiving treatment in the last 3 months
•Lack of sensitivity to the studied drugs
•Having at least three depigmented patches at the end of the limb

排除标准

•Pregnancy and breastfeeding
•A history of scar and keloid formation in the body
•Received treatment in the last three months
•Presence of active vitiligo in the last 2 years

研究者

发起方

Esfahan University of Medical Sciences

相似试验

Casts and bandages in fractures without displacement of the distal radiusundisplaced distal radius fractures.Fracture of lower end of both ulna and radius

IRCT2016040627247N1Vice chancellor for research, Ahvaz Jondishapour University of Medical Sciences60

进行中（未招募）

.a.patients with ulcerative colitisMedDRA version: 20.0Level: LLTClassification code 10045282Term: UCSystem Organ Class: 100000004856MedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856

EUCTR2016-002707-25-ITIRCCS ISTITUTO CLINICO HUMANITAS100

This is a study to test the effectiveness of electrical nerve stimulation treatment applying on superficial skin in patients having pain originating from nerves and muscles of facial region.

CTRI/2018/02/012068Dr G Swathi28

Comparison of three methods of treatment by using plate in the treatment of mandibular fractureFracture of mandible.Fracture of mandible

IRCT2017052834186N1Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences45

进行中（未招募）

Multi-arm randomized trial, comparing the efficacy of therapeutic strategies for at home early treatment of mild or moderate COVID-19 (SARS-CoV-2 infection) patients on the reduction of the risk of disease worsening

EUCTR2020-005890-29-ITFONDAZIONE RICERCA TRASLAZIONALE (FORT)810